Autolus Therapeutics AUTL Estimates

NASDAQ AUTL
$1.86 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Autolus Therapeutics plc Quarterly Revenue Estimates

Periods 12
Next Period Q3 26
Consensus 41.22 M

Analysts expect Autolus Therapeutics plc to report revenue of 41.22 M for Q3 26, against a range of 37.58 M to 44.86 M. The most recent reported quarter, Q2 26, came in at 45.69 M, a 13.4% beat against the 40.29 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 0.0029,000.008.98 M20.92 M21.19 M24.29 M26.22 M45.69 M----
High Estimate 151,555.473.28 M2.37 M14.82 M23.60 M24.98 M26.73 M42.22 M44.86 M42.69 M43.57 M44.06 M
Low Estimate 140,289.392.75 M1.97 M13.04 M21.41 M20.49 M24.63 M38.36 M37.58 M36.23 M37.21 M39.48 M
Consensus Estimate 145,922.433.01 M2.17 M13.93 M22.51 M22.74 M25.68 M40.29 M41.22 M39.46 M40.39 M41.77 M
Analyst Estimates

Autolus Therapeutics plc Quarterly Earnings Per Share (EPS) Estimates

Periods 12
Next Period Q3 26
Consensus -0.17

Analysts expect Autolus Therapeutics plc to report earnings per share of -0.17 for Q3 26, against a range of -0.18 to -0.16. The most recent reported quarter, Q2 26, came in at -0.15, a 25.0% beat against the -0.20 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) -0.31-0.09-0.26-0.18-0.30-0.34-0.27-0.15----
High Estimate -0.19-0.18-0.21-0.19-0.19-0.26-0.25-0.18-0.16-0.16-0.14-0.15
Low Estimate -0.21-0.22-0.23-0.23-0.23-0.30-0.27-0.22-0.18-0.16-0.16-0.17
Consensus Estimate -0.20-0.20-0.22-0.21-0.21-0.28-0.26-0.20-0.17-0.16-0.15-0.16

Autolus Therapeutics plc Estimates API

Pull Wall Street consensus for Autolus Therapeutics plc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=AUTL&mode=revenue&api_key=YOUR_API_KEY